1-[2-fluoro-3-methoxy-6-(1-methylpyrazol-4-yl)-4-nitrophenyl]piperidin-4-one
C16H17FN4O4 — CID 168838639
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-fluoro-3-methoxy-6-(1-methylpyrazol-4-yl)-4-nitrophenyl]piperidin-4-one
1-[2-fluoro-3-methoxy-6-(1-methylpyrazol-4-yl)-4-nitrophenyl]piperidin-4-one (PubChem CID 168838639) has the molecular formula C16H17FN4O4 and a molecular weight of 348.33 g/mol. Its IUPAC name is 1-[2-fluoro-3-methoxy-6-(1-methylpyrazol-4-yl)-4-nitrophenyl]piperidin-4-one.
Molecular Properties
| Compound Name | 1-[2-fluoro-3-methoxy-6-(1-methylpyrazol-4-yl)-4-nitrophenyl]piperidin-4-one |
|---|---|
| PubChem CID | 168838639 |
| Molecular Formula | C16H17FN4O4 |
| Molecular Weight | 348.33 g/mol |
| Exact Mass | 348.12 |
| IUPAC Name | 1-[2-fluoro-3-methoxy-6-(1-methylpyrazol-4-yl)-4-nitrophenyl]piperidin-4-one |
| SMILES | COc1c([N+](=O)[O-])cc(-c2cnn(C)c2)c(N2CCC(=O)CC2)c1F |
| InChI | InChI=1S/C16H17FN4O4/c1-19-9-10(8-18-19)12-7-13(21(23)24)16(25-2)14(17)15(12)20-5-3-11(22)4-6-20/h7-9H,3-6H2,1-2H3 |
| InChIKey | SEKNUYHRSDBJBM-UHFFFAOYSA-N |
| XLogP | 2.31 |
| TPSA | 90.50 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 348.33 |
| LogP ≤ 5 | 2.31 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168838639 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.